About this episode

Martin Pacesa discusses how BindCraft is transforming the protein design industry and its implications for drug development.

How is BindCraft, the automated pipeline for de novo protein binder design, changing the protein design industry? Martin Pacesa, assistant professor of pharmacology at the University of Zurich, joins The Chain to discuss how BindCraft is helping non-protein designers learn how to design proteins—and how the role of the protein designer will evolve. With host Chris Bahl, their conversation explores how BindCraft may help with drug development, its role in the democratization of tools and resou...

Explore listener stats, chart rankings, contacts and more on the The Chain: Protein Engineering Podcast podcast page.